Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Cash from Investing Activities (2023)

Xenetic Biosciences (XBIO) has disclosed Cash from Investing Activities for 1 consecutive years, with -$212500.0 as the latest value for Q2 2013.

  • For the quarter ending Q2 2013, Cash from Investing Activities changed N/A year-over-year to -$212500.0, compared with a TTM value of -$425000.0 through Dec 2023, changed N/A, and an annual FY2022 reading of -$500000.0, changed N/A over the prior year.
  • Cash from Investing Activities was -$212500.0 for Q2 2013 at Xenetic Biosciences, roughly flat from -$212500.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$212500.0 in Q1 2013 and bottomed at -$212500.0 in Q1 2013.